Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer Article Swipe
Aleix Prat
,
Valentina Guarneri
,
Tomás Pascual
,
Fara Brasó‐Maristany
,
Esther Sanfeliu
,
Laia Paré
,
Francesco Schettini
,
Eduardo Martínez de Dueñas
,
Pedro Jares
,
Gaia Griguolo
,
Maria Vittoria Dieci
,
Javier Cortés
,
Antonio Llombart‐Cussac
,
Benedetta Conte
,
Mercedes Marín‐Aguilera
,
Núria Chic
,
Joan Anton Puig‐Butillé
,
Antonio Martı́nez
,
Patricia Galván
,
Yi‐Hsuan Tsai
,
Blanca González‐Farré
,
Áurea Mira
,
Ana Vivancos
,
Patricia Villagrasa
,
Joel S. Parker
,
Pierfranco Conté
,
Charles M. Perou
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1016/j.ebiom.2021.103801
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1016/j.ebiom.2021.103801
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.ebiom.2021.103801
- http://www.thelancet.com/article/S2352396421005958/pdf
- OA Status
- gold
- Cited By
- 121
- References
- 45
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4206283263
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4206283263Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.ebiom.2021.103801Digital Object Identifier
- Title
-
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancerWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-01-01Full publication date if available
- Authors
-
Aleix Prat, Valentina Guarneri, Tomás Pascual, Fara Brasó‐Maristany, Esther Sanfeliu, Laia Paré, Francesco Schettini, Eduardo Martínez de Dueñas, Pedro Jares, Gaia Griguolo, Maria Vittoria Dieci, Javier Cortés, Antonio Llombart‐Cussac, Benedetta Conte, Mercedes Marín‐Aguilera, Núria Chic, Joan Anton Puig‐Butillé, Antonio Martı́nez, Patricia Galván, Yi‐Hsuan Tsai, Blanca González‐Farré, Áurea Mira, Ana Vivancos, Patricia Villagrasa, Joel S. Parker, Pierfranco Conté, Charles M. PerouList of authors in order
- Landing page
-
https://doi.org/10.1016/j.ebiom.2021.103801Publisher landing page
- PDF URL
-
https://www.thelancet.com/article/S2352396421005958/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.thelancet.com/article/S2352396421005958/pdfDirect OA link when available
- Concepts
-
Oncology, Medicine, Cohort, Internal medicine, Breast cancer, Framingham Risk Score, Stage (stratigraphy), Neoadjuvant therapy, Pathological, Receiver operating characteristic, Cancer, Disease, Biology, PaleontologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
121Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 40, 2024: 36, 2023: 33, 2022: 12Per-year citation counts (last 5 years)
- References (count)
-
45Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4206283263 |
|---|---|
| doi | https://doi.org/10.1016/j.ebiom.2021.103801 |
| ids.doi | https://doi.org/10.1016/j.ebiom.2021.103801 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/34990895 |
| ids.openalex | https://openalex.org/W4206283263 |
| fwci | 18.02472811 |
| mesh[0].qualifier_ui | Q000627 |
| mesh[0].descriptor_ui | D000971 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | therapeutic use |
| mesh[0].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[1].qualifier_ui | Q000188 |
| mesh[1].descriptor_ui | D001943 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | drug therapy |
| mesh[1].descriptor_name | Breast Neoplasms |
| mesh[2].qualifier_ui | Q000235 |
| mesh[2].descriptor_ui | D001943 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | genetics |
| mesh[2].descriptor_name | Breast Neoplasms |
| mesh[3].qualifier_ui | Q000473 |
| mesh[3].descriptor_ui | D001943 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | pathology |
| mesh[3].descriptor_name | Breast Neoplasms |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D017024 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Chemotherapy, Adjuvant |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D018572 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Disease-Free Survival |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D005260 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Female |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D006801 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Humans |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D020360 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Neoadjuvant Therapy |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D011379 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Prognosis |
| mesh[10].qualifier_ui | Q000235 |
| mesh[10].descriptor_ui | D018719 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | genetics |
| mesh[10].descriptor_name | Receptor, ErbB-2 |
| mesh[11].qualifier_ui | Q000378 |
| mesh[11].descriptor_ui | D018719 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | metabolism |
| mesh[11].descriptor_name | Receptor, ErbB-2 |
| mesh[12].qualifier_ui | Q000627 |
| mesh[12].descriptor_ui | D000068878 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | therapeutic use |
| mesh[12].descriptor_name | Trastuzumab |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D016896 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Treatment Outcome |
| mesh[14].qualifier_ui | Q000627 |
| mesh[14].descriptor_ui | D000971 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | therapeutic use |
| mesh[14].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[15].qualifier_ui | Q000188 |
| mesh[15].descriptor_ui | D001943 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | drug therapy |
| mesh[15].descriptor_name | Breast Neoplasms |
| mesh[16].qualifier_ui | Q000235 |
| mesh[16].descriptor_ui | D001943 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | genetics |
| mesh[16].descriptor_name | Breast Neoplasms |
| mesh[17].qualifier_ui | Q000473 |
| mesh[17].descriptor_ui | D001943 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | pathology |
| mesh[17].descriptor_name | Breast Neoplasms |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D017024 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Chemotherapy, Adjuvant |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D018572 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Disease-Free Survival |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D005260 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Female |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D006801 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Humans |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D020360 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Neoadjuvant Therapy |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D011379 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Prognosis |
| mesh[24].qualifier_ui | Q000235 |
| mesh[24].descriptor_ui | D018719 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | genetics |
| mesh[24].descriptor_name | Receptor, ErbB-2 |
| mesh[25].qualifier_ui | Q000378 |
| mesh[25].descriptor_ui | D018719 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | metabolism |
| mesh[25].descriptor_name | Receptor, ErbB-2 |
| mesh[26].qualifier_ui | Q000627 |
| mesh[26].descriptor_ui | D000068878 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | therapeutic use |
| mesh[26].descriptor_name | Trastuzumab |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D016896 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Treatment Outcome |
| type | article |
| title | Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer |
| biblio.issue | |
| biblio.volume | 75 |
| biblio.last_page | 103801 |
| biblio.first_page | 103801 |
| topics[0].id | https://openalex.org/T10755 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | HER2/EGFR in Cancer Research |
| topics[1].id | https://openalex.org/T10336 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9988999962806702 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Cancer Cells and Metastasis |
| topics[2].id | https://openalex.org/T10183 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9983999729156494 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1306 |
| topics[2].subfield.display_name | Cancer Research |
| topics[2].display_name | Breast Cancer Treatment Studies |
| funders[0].id | https://openalex.org/F4320307765 |
| funders[0].ror | https://ror.org/01xdqrp08 |
| funders[0].display_name | Pfizer |
| funders[1].id | https://openalex.org/F4320308573 |
| funders[1].ror | https://ror.org/056546b03 |
| funders[1].display_name | Gilead Sciences |
| is_xpac | False |
| apc_list.value | 3500 |
| apc_list.currency | USD |
| apc_list.value_usd | 3500 |
| apc_paid.value | 3500 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3500 |
| concepts[0].id | https://openalex.org/C143998085 |
| concepts[0].level | 1 |
| concepts[0].score | 0.6997249126434326 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[0].display_name | Oncology |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.6802157759666443 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C72563966 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6355699300765991 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[2].display_name | Cohort |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6335619688034058 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C530470458 |
| concepts[4].level | 3 |
| concepts[4].score | 0.6102499961853027 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[4].display_name | Breast cancer |
| concepts[5].id | https://openalex.org/C11783203 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5056138038635254 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q5478027 |
| concepts[5].display_name | Framingham Risk Score |
| concepts[6].id | https://openalex.org/C146357865 |
| concepts[6].level | 2 |
| concepts[6].score | 0.49816083908081055 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1123245 |
| concepts[6].display_name | Stage (stratigraphy) |
| concepts[7].id | https://openalex.org/C2778292576 |
| concepts[7].level | 4 |
| concepts[7].score | 0.49261122941970825 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q6991934 |
| concepts[7].display_name | Neoadjuvant therapy |
| concepts[8].id | https://openalex.org/C207886595 |
| concepts[8].level | 2 |
| concepts[8].score | 0.47102460265159607 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1456138 |
| concepts[8].display_name | Pathological |
| concepts[9].id | https://openalex.org/C58471807 |
| concepts[9].level | 2 |
| concepts[9].score | 0.41540247201919556 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q327120 |
| concepts[9].display_name | Receiver operating characteristic |
| concepts[10].id | https://openalex.org/C121608353 |
| concepts[10].level | 2 |
| concepts[10].score | 0.39240574836730957 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[10].display_name | Cancer |
| concepts[11].id | https://openalex.org/C2779134260 |
| concepts[11].level | 2 |
| concepts[11].score | 0.3459692597389221 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[11].display_name | Disease |
| concepts[12].id | https://openalex.org/C86803240 |
| concepts[12].level | 0 |
| concepts[12].score | 0.1349458396434784 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[12].display_name | Biology |
| concepts[13].id | https://openalex.org/C151730666 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7205 |
| concepts[13].display_name | Paleontology |
| keywords[0].id | https://openalex.org/keywords/oncology |
| keywords[0].score | 0.6997249126434326 |
| keywords[0].display_name | Oncology |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.6802157759666443 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/cohort |
| keywords[2].score | 0.6355699300765991 |
| keywords[2].display_name | Cohort |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.6335619688034058 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/breast-cancer |
| keywords[4].score | 0.6102499961853027 |
| keywords[4].display_name | Breast cancer |
| keywords[5].id | https://openalex.org/keywords/framingham-risk-score |
| keywords[5].score | 0.5056138038635254 |
| keywords[5].display_name | Framingham Risk Score |
| keywords[6].id | https://openalex.org/keywords/stage |
| keywords[6].score | 0.49816083908081055 |
| keywords[6].display_name | Stage (stratigraphy) |
| keywords[7].id | https://openalex.org/keywords/neoadjuvant-therapy |
| keywords[7].score | 0.49261122941970825 |
| keywords[7].display_name | Neoadjuvant therapy |
| keywords[8].id | https://openalex.org/keywords/pathological |
| keywords[8].score | 0.47102460265159607 |
| keywords[8].display_name | Pathological |
| keywords[9].id | https://openalex.org/keywords/receiver-operating-characteristic |
| keywords[9].score | 0.41540247201919556 |
| keywords[9].display_name | Receiver operating characteristic |
| keywords[10].id | https://openalex.org/keywords/cancer |
| keywords[10].score | 0.39240574836730957 |
| keywords[10].display_name | Cancer |
| keywords[11].id | https://openalex.org/keywords/disease |
| keywords[11].score | 0.3459692597389221 |
| keywords[11].display_name | Disease |
| keywords[12].id | https://openalex.org/keywords/biology |
| keywords[12].score | 0.1349458396434784 |
| keywords[12].display_name | Biology |
| language | en |
| locations[0].id | doi:10.1016/j.ebiom.2021.103801 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2531685872 |
| locations[0].source.issn | 2352-3964 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2352-3964 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | EBioMedicine |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_lineage_names | Elsevier BV |
| locations[0].license | cc-by |
| locations[0].pdf_url | http://www.thelancet.com/article/S2352396421005958/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | eBioMedicine |
| locations[0].landing_page_url | https://doi.org/10.1016/j.ebiom.2021.103801 |
| locations[1].id | pmid:34990895 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | EBioMedicine |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/34990895 |
| locations[2].id | pmh:oai:diposit.ub.edu:2445/194403 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306401653 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) |
| locations[2].source.host_organization | https://openalex.org/I71999127 |
| locations[2].source.host_organization_name | Universitat de Barcelona |
| locations[2].source.host_organization_lineage | https://openalex.org/I71999127 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | info:eu-repo/semantics/article |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Articles publicats en revistes (Medicina) |
| locations[2].landing_page_url | http://hdl.handle.net/2445/194403 |
| locations[3].id | pmh:oai:doaj.org/article:0fd537b853eb4d46994417b689144024 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306401280 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[3].source.host_organization | |
| locations[3].source.host_organization_name | |
| locations[3].license | cc-by-sa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | article |
| locations[3].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | EBioMedicine, Vol 75, Iss , Pp 103801- (2022) |
| locations[3].landing_page_url | https://doaj.org/article/0fd537b853eb4d46994417b689144024 |
| locations[4].id | pmh:oai:pubmedcentral.nih.gov:8741424 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S2764455111 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | PubMed Central |
| locations[4].source.host_organization | https://openalex.org/I1299303238 |
| locations[4].source.host_organization_name | National Institutes of Health |
| locations[4].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[4].license | other-oa |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | Text |
| locations[4].license_id | https://openalex.org/licenses/other-oa |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | EBioMedicine |
| locations[4].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/8741424 |
| locations[5].id | pmh:oai:www.research.unipd.it:11577/3410925 |
| locations[5].is_oa | True |
| locations[5].source.id | https://openalex.org/S4306402448 |
| locations[5].source.issn | |
| locations[5].source.type | repository |
| locations[5].source.is_oa | False |
| locations[5].source.issn_l | |
| locations[5].source.is_core | False |
| locations[5].source.is_in_doaj | False |
| locations[5].source.display_name | Padua Research Archive (University of Padua) |
| locations[5].source.host_organization | https://openalex.org/I138689650 |
| locations[5].source.host_organization_name | University of Padua |
| locations[5].source.host_organization_lineage | https://openalex.org/I138689650 |
| locations[5].license | cc-by |
| locations[5].pdf_url | |
| locations[5].version | submittedVersion |
| locations[5].raw_type | info:eu-repo/semantics/article |
| locations[5].license_id | https://openalex.org/licenses/cc-by |
| locations[5].is_accepted | False |
| locations[5].is_published | False |
| locations[5].raw_source_name | |
| locations[5].landing_page_url | https://www.sciencedirect.com/science/article/pii/S2352396421005958 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5089513581 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-2377-540X |
| authorships[0].author.display_name | Aleix Prat |
| authorships[0].countries | ES |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210133410 |
| authorships[0].affiliations[0].raw_affiliation_string | SOLTI cooperative group, Barcelona, Spain |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I4210114273 |
| authorships[0].affiliations[1].raw_affiliation_string | Institute of Oncology (IOB)-Hospital Quirónsalud, Barcelona, Spain |
| authorships[0].affiliations[2].institution_ids | https://openalex.org/I4210115097 |
| authorships[0].affiliations[2].raw_affiliation_string | Department of Medical Oncology, Hospital Clinic of Barcelona, Spain |
| authorships[0].affiliations[3].institution_ids | https://openalex.org/I4210160192 |
| authorships[0].affiliations[3].raw_affiliation_string | Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[0].affiliations[4].institution_ids | https://openalex.org/I71999127 |
| authorships[0].affiliations[4].raw_affiliation_string | Department of Medicine, University of Barcelona, Barcelona, Spain |
| authorships[0].institutions[0].id | https://openalex.org/I4210160192 |
| authorships[0].institutions[0].ror | https://ror.org/054vayn55 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210160192, https://openalex.org/I4387153040 |
| authorships[0].institutions[0].country_code | ES |
| authorships[0].institutions[0].display_name | Consorci Institut D'Investigacions Biomediques August Pi I Sunyer |
| authorships[0].institutions[1].id | https://openalex.org/I4210115097 |
| authorships[0].institutions[1].ror | https://ror.org/02a2kzf50 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210115097 |
| authorships[0].institutions[1].country_code | ES |
| authorships[0].institutions[1].display_name | Hospital Clínic de Barcelona |
| authorships[0].institutions[2].id | https://openalex.org/I4210114273 |
| authorships[0].institutions[2].ror | https://ror.org/02558h854 |
| authorships[0].institutions[2].type | healthcare |
| authorships[0].institutions[2].lineage | https://openalex.org/I4210114273 |
| authorships[0].institutions[2].country_code | ES |
| authorships[0].institutions[2].display_name | Hospital Quirónsalud Barcelona |
| authorships[0].institutions[3].id | https://openalex.org/I4210133410 |
| authorships[0].institutions[3].ror | https://ror.org/03xb7kp74 |
| authorships[0].institutions[3].type | nonprofit |
| authorships[0].institutions[3].lineage | https://openalex.org/I4210133410 |
| authorships[0].institutions[3].country_code | ES |
| authorships[0].institutions[3].display_name | Solti |
| authorships[0].institutions[4].id | https://openalex.org/I71999127 |
| authorships[0].institutions[4].ror | https://ror.org/021018s57 |
| authorships[0].institutions[4].type | education |
| authorships[0].institutions[4].lineage | https://openalex.org/I71999127 |
| authorships[0].institutions[4].country_code | ES |
| authorships[0].institutions[4].display_name | Universitat de Barcelona |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Aleix Prat |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Medical Oncology, Hospital Clinic of Barcelona, Spain, Department of Medicine, University of Barcelona, Barcelona, Spain, Institute of Oncology (IOB)-Hospital Quirónsalud, Barcelona, Spain, SOLTI cooperative group, Barcelona, Spain, Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[1].author.id | https://openalex.org/A5034632931 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2375-8397 |
| authorships[1].author.display_name | Valentina Guarneri |
| authorships[1].countries | IT |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210109345, https://openalex.org/I4210153126 |
| authorships[1].affiliations[0].raw_affiliation_string | Medical Oncology 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I138689650 |
| authorships[1].affiliations[1].raw_affiliation_string | Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy |
| authorships[1].institutions[0].id | https://openalex.org/I4210153126 |
| authorships[1].institutions[0].ror | https://ror.org/04tfzc498 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210153126 |
| authorships[1].institutions[0].country_code | IT |
| authorships[1].institutions[0].display_name | Istituti di Ricovero e Cura a Carattere Scientifico |
| authorships[1].institutions[1].id | https://openalex.org/I4210109345 |
| authorships[1].institutions[1].ror | https://ror.org/01xcjmy57 |
| authorships[1].institutions[1].type | healthcare |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210109345, https://openalex.org/I4210153126 |
| authorships[1].institutions[1].country_code | IT |
| authorships[1].institutions[1].display_name | Istituto Oncologico Veneto |
| authorships[1].institutions[2].id | https://openalex.org/I138689650 |
| authorships[1].institutions[2].ror | https://ror.org/00240q980 |
| authorships[1].institutions[2].type | education |
| authorships[1].institutions[2].lineage | https://openalex.org/I138689650 |
| authorships[1].institutions[2].country_code | IT |
| authorships[1].institutions[2].display_name | University of Padua |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Valentina Guarneri |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy, Medical Oncology 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy |
| authorships[2].author.id | https://openalex.org/A5043895722 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-8431-3183 |
| authorships[2].author.display_name | Tomás Pascual |
| authorships[2].countries | ES |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210133410 |
| authorships[2].affiliations[0].raw_affiliation_string | SOLTI cooperative group, Barcelona, Spain |
| authorships[2].institutions[0].id | https://openalex.org/I4210133410 |
| authorships[2].institutions[0].ror | https://ror.org/03xb7kp74 |
| authorships[2].institutions[0].type | nonprofit |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210133410 |
| authorships[2].institutions[0].country_code | ES |
| authorships[2].institutions[0].display_name | Solti |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Tomás Pascual |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | SOLTI cooperative group, Barcelona, Spain |
| authorships[3].author.id | https://openalex.org/A5014379154 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5440-9643 |
| authorships[3].author.display_name | Fara Brasó‐Maristany |
| authorships[3].countries | ES |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210160192 |
| authorships[3].affiliations[0].raw_affiliation_string | Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[3].institutions[0].id | https://openalex.org/I4210160192 |
| authorships[3].institutions[0].ror | https://ror.org/054vayn55 |
| authorships[3].institutions[0].type | facility |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210160192, https://openalex.org/I4387153040 |
| authorships[3].institutions[0].country_code | ES |
| authorships[3].institutions[0].display_name | Consorci Institut D'Investigacions Biomediques August Pi I Sunyer |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Fara Brasó-Maristany |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[4].author.id | https://openalex.org/A5069211092 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-7974-3346 |
| authorships[4].author.display_name | Esther Sanfeliu |
| authorships[4].countries | ES |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210160192 |
| authorships[4].affiliations[0].raw_affiliation_string | Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I4210115097 |
| authorships[4].affiliations[1].raw_affiliation_string | Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain |
| authorships[4].institutions[0].id | https://openalex.org/I4210160192 |
| authorships[4].institutions[0].ror | https://ror.org/054vayn55 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210160192, https://openalex.org/I4387153040 |
| authorships[4].institutions[0].country_code | ES |
| authorships[4].institutions[0].display_name | Consorci Institut D'Investigacions Biomediques August Pi I Sunyer |
| authorships[4].institutions[1].id | https://openalex.org/I4210115097 |
| authorships[4].institutions[1].ror | https://ror.org/02a2kzf50 |
| authorships[4].institutions[1].type | healthcare |
| authorships[4].institutions[1].lineage | https://openalex.org/I4210115097 |
| authorships[4].institutions[1].country_code | ES |
| authorships[4].institutions[1].display_name | Hospital Clínic de Barcelona |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Esther Sanfeliu |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain, Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[5].author.id | https://openalex.org/A5070297345 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-4904-558X |
| authorships[5].author.display_name | Laia Paré |
| authorships[5].countries | ES |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210144086 |
| authorships[5].affiliations[0].raw_affiliation_string | Reveal Genomics, Barcelona, Spain |
| authorships[5].institutions[0].id | https://openalex.org/I4210144086 |
| authorships[5].institutions[0].ror | https://ror.org/03n5zh241 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210144086 |
| authorships[5].institutions[0].country_code | ES |
| authorships[5].institutions[0].display_name | Oryzon Genomics (Spain) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Laia Paré |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Reveal Genomics, Barcelona, Spain |
| authorships[6].author.id | https://openalex.org/A5008991955 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-6561-1919 |
| authorships[6].author.display_name | Francesco Schettini |
| authorships[6].countries | ES |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210133410 |
| authorships[6].affiliations[0].raw_affiliation_string | SOLTI cooperative group, Barcelona, Spain |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I4210115097 |
| authorships[6].affiliations[1].raw_affiliation_string | Department of Medical Oncology, Hospital Clinic of Barcelona, Spain |
| authorships[6].affiliations[2].institution_ids | https://openalex.org/I4210160192 |
| authorships[6].affiliations[2].raw_affiliation_string | Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[6].institutions[0].id | https://openalex.org/I4210160192 |
| authorships[6].institutions[0].ror | https://ror.org/054vayn55 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210160192, https://openalex.org/I4387153040 |
| authorships[6].institutions[0].country_code | ES |
| authorships[6].institutions[0].display_name | Consorci Institut D'Investigacions Biomediques August Pi I Sunyer |
| authorships[6].institutions[1].id | https://openalex.org/I4210115097 |
| authorships[6].institutions[1].ror | https://ror.org/02a2kzf50 |
| authorships[6].institutions[1].type | healthcare |
| authorships[6].institutions[1].lineage | https://openalex.org/I4210115097 |
| authorships[6].institutions[1].country_code | ES |
| authorships[6].institutions[1].display_name | Hospital Clínic de Barcelona |
| authorships[6].institutions[2].id | https://openalex.org/I4210133410 |
| authorships[6].institutions[2].ror | https://ror.org/03xb7kp74 |
| authorships[6].institutions[2].type | nonprofit |
| authorships[6].institutions[2].lineage | https://openalex.org/I4210133410 |
| authorships[6].institutions[2].country_code | ES |
| authorships[6].institutions[2].display_name | Solti |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Francesco Schettini |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Medical Oncology, Hospital Clinic of Barcelona, Spain, SOLTI cooperative group, Barcelona, Spain, Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[7].author.id | https://openalex.org/A5075269446 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-0110-4816 |
| authorships[7].author.display_name | Eduardo Martínez de Dueñas |
| authorships[7].countries | ES |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210160192 |
| authorships[7].affiliations[0].raw_affiliation_string | Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[7].institutions[0].id | https://openalex.org/I4210160192 |
| authorships[7].institutions[0].ror | https://ror.org/054vayn55 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210160192, https://openalex.org/I4387153040 |
| authorships[7].institutions[0].country_code | ES |
| authorships[7].institutions[0].display_name | Consorci Institut D'Investigacions Biomediques August Pi I Sunyer |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Débora Martínez |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[8].author.id | https://openalex.org/A5005178530 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-8401-579X |
| authorships[8].author.display_name | Pedro Jares |
| authorships[8].countries | ES |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210115097 |
| authorships[8].affiliations[0].raw_affiliation_string | Molecular Biology CORE laboratory, Hospital Clinic de Barcelona, Barcelona, Spain |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I4210115097 |
| authorships[8].affiliations[1].raw_affiliation_string | Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain |
| authorships[8].institutions[0].id | https://openalex.org/I4210115097 |
| authorships[8].institutions[0].ror | https://ror.org/02a2kzf50 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210115097 |
| authorships[8].institutions[0].country_code | ES |
| authorships[8].institutions[0].display_name | Hospital Clínic de Barcelona |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Pedro Jares |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain, Molecular Biology CORE laboratory, Hospital Clinic de Barcelona, Barcelona, Spain |
| authorships[9].author.id | https://openalex.org/A5085165482 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-8782-4509 |
| authorships[9].author.display_name | Gaia Griguolo |
| authorships[9].countries | IT |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I138689650 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I4210109345, https://openalex.org/I4210153126 |
| authorships[9].affiliations[1].raw_affiliation_string | Medical Oncology 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy |
| authorships[9].institutions[0].id | https://openalex.org/I4210153126 |
| authorships[9].institutions[0].ror | https://ror.org/04tfzc498 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210153126 |
| authorships[9].institutions[0].country_code | IT |
| authorships[9].institutions[0].display_name | Istituti di Ricovero e Cura a Carattere Scientifico |
| authorships[9].institutions[1].id | https://openalex.org/I4210109345 |
| authorships[9].institutions[1].ror | https://ror.org/01xcjmy57 |
| authorships[9].institutions[1].type | healthcare |
| authorships[9].institutions[1].lineage | https://openalex.org/I4210109345, https://openalex.org/I4210153126 |
| authorships[9].institutions[1].country_code | IT |
| authorships[9].institutions[1].display_name | Istituto Oncologico Veneto |
| authorships[9].institutions[2].id | https://openalex.org/I138689650 |
| authorships[9].institutions[2].ror | https://ror.org/00240q980 |
| authorships[9].institutions[2].type | education |
| authorships[9].institutions[2].lineage | https://openalex.org/I138689650 |
| authorships[9].institutions[2].country_code | IT |
| authorships[9].institutions[2].display_name | University of Padua |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Gaia Griguolo |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy, Medical Oncology 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy |
| authorships[10].author.id | https://openalex.org/A5081552375 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-3967-9861 |
| authorships[10].author.display_name | Maria Vittoria Dieci |
| authorships[10].countries | IT |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I138689650 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I4210109345, https://openalex.org/I4210153126 |
| authorships[10].affiliations[1].raw_affiliation_string | Medical Oncology 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy |
| authorships[10].institutions[0].id | https://openalex.org/I4210153126 |
| authorships[10].institutions[0].ror | https://ror.org/04tfzc498 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210153126 |
| authorships[10].institutions[0].country_code | IT |
| authorships[10].institutions[0].display_name | Istituti di Ricovero e Cura a Carattere Scientifico |
| authorships[10].institutions[1].id | https://openalex.org/I4210109345 |
| authorships[10].institutions[1].ror | https://ror.org/01xcjmy57 |
| authorships[10].institutions[1].type | healthcare |
| authorships[10].institutions[1].lineage | https://openalex.org/I4210109345, https://openalex.org/I4210153126 |
| authorships[10].institutions[1].country_code | IT |
| authorships[10].institutions[1].display_name | Istituto Oncologico Veneto |
| authorships[10].institutions[2].id | https://openalex.org/I138689650 |
| authorships[10].institutions[2].ror | https://ror.org/00240q980 |
| authorships[10].institutions[2].type | education |
| authorships[10].institutions[2].lineage | https://openalex.org/I138689650 |
| authorships[10].institutions[2].country_code | IT |
| authorships[10].institutions[2].display_name | University of Padua |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Maria Vittoria Dieci |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy, Medical Oncology 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy |
| authorships[11].author.id | https://openalex.org/A5051629490 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-7623-1583 |
| authorships[11].author.display_name | Javier Cortés |
| authorships[11].affiliations[0].raw_affiliation_string | Institute of Oncology (IOB)-Quiron, Madrid, Spain |
| authorships[11].affiliations[1].institution_ids | https://openalex.org/I4387155398 |
| authorships[11].affiliations[1].raw_affiliation_string | Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain |
| authorships[11].institutions[0].id | https://openalex.org/I4387155398 |
| authorships[11].institutions[0].ror | https://ror.org/054xx3904 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4387153040, https://openalex.org/I4387155398 |
| authorships[11].institutions[0].country_code | |
| authorships[11].institutions[0].display_name | Vall d'Hebron Institute of Oncology |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Javier Cortés |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Institute of Oncology (IOB)-Quiron, Madrid, Spain, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain |
| authorships[12].author.id | https://openalex.org/A5030451537 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-4515-8293 |
| authorships[12].author.display_name | Antonio Llombart‐Cussac |
| authorships[12].countries | ES |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210119293 |
| authorships[12].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Hospital Arnau de Vilanova, Valencia, Spain |
| authorships[12].institutions[0].id | https://openalex.org/I4210119293 |
| authorships[12].institutions[0].ror | https://ror.org/02s7fkk92 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210119293 |
| authorships[12].institutions[0].country_code | ES |
| authorships[12].institutions[0].display_name | Hospital Arnau de Vilanova |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Antonio Llombart-Cussac |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Department of Medical Oncology, Hospital Arnau de Vilanova, Valencia, Spain |
| authorships[13].author.id | https://openalex.org/A5051951830 |
| authorships[13].author.orcid | https://orcid.org/0000-0003-4720-2497 |
| authorships[13].author.display_name | Benedetta Conte |
| authorships[13].countries | ES |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210133410 |
| authorships[13].affiliations[0].raw_affiliation_string | SOLTI cooperative group, Barcelona, Spain |
| authorships[13].affiliations[1].institution_ids | https://openalex.org/I4210160192 |
| authorships[13].affiliations[1].raw_affiliation_string | Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[13].affiliations[2].institution_ids | https://openalex.org/I4210115097 |
| authorships[13].affiliations[2].raw_affiliation_string | Department of Medical Oncology, Hospital Clinic of Barcelona, Spain |
| authorships[13].institutions[0].id | https://openalex.org/I4210160192 |
| authorships[13].institutions[0].ror | https://ror.org/054vayn55 |
| authorships[13].institutions[0].type | facility |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210160192, https://openalex.org/I4387153040 |
| authorships[13].institutions[0].country_code | ES |
| authorships[13].institutions[0].display_name | Consorci Institut D'Investigacions Biomediques August Pi I Sunyer |
| authorships[13].institutions[1].id | https://openalex.org/I4210115097 |
| authorships[13].institutions[1].ror | https://ror.org/02a2kzf50 |
| authorships[13].institutions[1].type | healthcare |
| authorships[13].institutions[1].lineage | https://openalex.org/I4210115097 |
| authorships[13].institutions[1].country_code | ES |
| authorships[13].institutions[1].display_name | Hospital Clínic de Barcelona |
| authorships[13].institutions[2].id | https://openalex.org/I4210133410 |
| authorships[13].institutions[2].ror | https://ror.org/03xb7kp74 |
| authorships[13].institutions[2].type | nonprofit |
| authorships[13].institutions[2].lineage | https://openalex.org/I4210133410 |
| authorships[13].institutions[2].country_code | ES |
| authorships[13].institutions[2].display_name | Solti |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Benedetta Conte |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Department of Medical Oncology, Hospital Clinic of Barcelona, Spain, SOLTI cooperative group, Barcelona, Spain, Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[14].author.id | https://openalex.org/A5085349056 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Mercedes Marín‐Aguilera |
| authorships[14].countries | ES |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210144086 |
| authorships[14].affiliations[0].raw_affiliation_string | Reveal Genomics, Barcelona, Spain |
| authorships[14].institutions[0].id | https://openalex.org/I4210144086 |
| authorships[14].institutions[0].ror | https://ror.org/03n5zh241 |
| authorships[14].institutions[0].type | company |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210144086 |
| authorships[14].institutions[0].country_code | ES |
| authorships[14].institutions[0].display_name | Oryzon Genomics (Spain) |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Mercedes Marín-Aguilera |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Reveal Genomics, Barcelona, Spain |
| authorships[15].author.id | https://openalex.org/A5077175788 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-9736-6276 |
| authorships[15].author.display_name | Núria Chic |
| authorships[15].countries | ES |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210115097 |
| authorships[15].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Hospital Clinic of Barcelona, Spain |
| authorships[15].affiliations[1].institution_ids | https://openalex.org/I4210133410 |
| authorships[15].affiliations[1].raw_affiliation_string | SOLTI cooperative group, Barcelona, Spain |
| authorships[15].affiliations[2].institution_ids | https://openalex.org/I4210160192 |
| authorships[15].affiliations[2].raw_affiliation_string | Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[15].institutions[0].id | https://openalex.org/I4210160192 |
| authorships[15].institutions[0].ror | https://ror.org/054vayn55 |
| authorships[15].institutions[0].type | facility |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210160192, https://openalex.org/I4387153040 |
| authorships[15].institutions[0].country_code | ES |
| authorships[15].institutions[0].display_name | Consorci Institut D'Investigacions Biomediques August Pi I Sunyer |
| authorships[15].institutions[1].id | https://openalex.org/I4210115097 |
| authorships[15].institutions[1].ror | https://ror.org/02a2kzf50 |
| authorships[15].institutions[1].type | healthcare |
| authorships[15].institutions[1].lineage | https://openalex.org/I4210115097 |
| authorships[15].institutions[1].country_code | ES |
| authorships[15].institutions[1].display_name | Hospital Clínic de Barcelona |
| authorships[15].institutions[2].id | https://openalex.org/I4210133410 |
| authorships[15].institutions[2].ror | https://ror.org/03xb7kp74 |
| authorships[15].institutions[2].type | nonprofit |
| authorships[15].institutions[2].lineage | https://openalex.org/I4210133410 |
| authorships[15].institutions[2].country_code | ES |
| authorships[15].institutions[2].display_name | Solti |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Nuria Chic |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Department of Medical Oncology, Hospital Clinic of Barcelona, Spain, SOLTI cooperative group, Barcelona, Spain, Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[16].author.id | https://openalex.org/A5091612621 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-4345-9631 |
| authorships[16].author.display_name | Joan Anton Puig‐Butillé |
| authorships[16].countries | ES |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210115097 |
| authorships[16].affiliations[0].raw_affiliation_string | Biochemistry and Molecular Genetics Service, Hospital Clinic de Barcelona, Barcelona, Spain |
| authorships[16].affiliations[1].institution_ids | https://openalex.org/I4210115097 |
| authorships[16].affiliations[1].raw_affiliation_string | Molecular Biology CORE laboratory, Hospital Clinic de Barcelona, Barcelona, Spain |
| authorships[16].institutions[0].id | https://openalex.org/I4210115097 |
| authorships[16].institutions[0].ror | https://ror.org/02a2kzf50 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210115097 |
| authorships[16].institutions[0].country_code | ES |
| authorships[16].institutions[0].display_name | Hospital Clínic de Barcelona |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Joan Anton Puig-Butillé |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Biochemistry and Molecular Genetics Service, Hospital Clinic de Barcelona, Barcelona, Spain, Molecular Biology CORE laboratory, Hospital Clinic de Barcelona, Barcelona, Spain |
| authorships[17].author.id | https://openalex.org/A5066377227 |
| authorships[17].author.orcid | https://orcid.org/0000-0003-0790-9017 |
| authorships[17].author.display_name | Antonio Martı́nez |
| authorships[17].countries | ES |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210115097 |
| authorships[17].affiliations[0].raw_affiliation_string | Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain |
| authorships[17].institutions[0].id | https://openalex.org/I4210115097 |
| authorships[17].institutions[0].ror | https://ror.org/02a2kzf50 |
| authorships[17].institutions[0].type | healthcare |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210115097 |
| authorships[17].institutions[0].country_code | ES |
| authorships[17].institutions[0].display_name | Hospital Clínic de Barcelona |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Antonio Martínez |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain |
| authorships[18].author.id | https://openalex.org/A5059201728 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-8153-0307 |
| authorships[18].author.display_name | Patricia Galván |
| authorships[18].countries | ES |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I4210160192 |
| authorships[18].affiliations[0].raw_affiliation_string | Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[18].institutions[0].id | https://openalex.org/I4210160192 |
| authorships[18].institutions[0].ror | https://ror.org/054vayn55 |
| authorships[18].institutions[0].type | facility |
| authorships[18].institutions[0].lineage | https://openalex.org/I4210160192, https://openalex.org/I4387153040 |
| authorships[18].institutions[0].country_code | ES |
| authorships[18].institutions[0].display_name | Consorci Institut D'Investigacions Biomediques August Pi I Sunyer |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Patricia Galván |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[19].author.id | https://openalex.org/A5071843228 |
| authorships[19].author.orcid | https://orcid.org/0000-0003-2107-4300 |
| authorships[19].author.display_name | Yi‐Hsuan Tsai |
| authorships[19].countries | ES |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I4210144086 |
| authorships[19].affiliations[0].raw_affiliation_string | Reveal Genomics, Barcelona, Spain |
| authorships[19].institutions[0].id | https://openalex.org/I4210144086 |
| authorships[19].institutions[0].ror | https://ror.org/03n5zh241 |
| authorships[19].institutions[0].type | company |
| authorships[19].institutions[0].lineage | https://openalex.org/I4210144086 |
| authorships[19].institutions[0].country_code | ES |
| authorships[19].institutions[0].display_name | Oryzon Genomics (Spain) |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Yi-Hsuan Tsai |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Reveal Genomics, Barcelona, Spain |
| authorships[20].author.id | https://openalex.org/A5042649658 |
| authorships[20].author.orcid | https://orcid.org/0000-0002-1796-7248 |
| authorships[20].author.display_name | Blanca González‐Farré |
| authorships[20].countries | ES |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I4210115097 |
| authorships[20].affiliations[0].raw_affiliation_string | Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain |
| authorships[20].affiliations[1].institution_ids | https://openalex.org/I4210160192 |
| authorships[20].affiliations[1].raw_affiliation_string | Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[20].institutions[0].id | https://openalex.org/I4210160192 |
| authorships[20].institutions[0].ror | https://ror.org/054vayn55 |
| authorships[20].institutions[0].type | facility |
| authorships[20].institutions[0].lineage | https://openalex.org/I4210160192, https://openalex.org/I4387153040 |
| authorships[20].institutions[0].country_code | ES |
| authorships[20].institutions[0].display_name | Consorci Institut D'Investigacions Biomediques August Pi I Sunyer |
| authorships[20].institutions[1].id | https://openalex.org/I4210115097 |
| authorships[20].institutions[1].ror | https://ror.org/02a2kzf50 |
| authorships[20].institutions[1].type | healthcare |
| authorships[20].institutions[1].lineage | https://openalex.org/I4210115097 |
| authorships[20].institutions[1].country_code | ES |
| authorships[20].institutions[1].display_name | Hospital Clínic de Barcelona |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Blanca González-Farré |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain, Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain |
| authorships[21].author.id | https://openalex.org/A5109259123 |
| authorships[21].author.orcid | |
| authorships[21].author.display_name | Áurea Mira |
| authorships[21].countries | ES |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I4210115097 |
| authorships[21].affiliations[0].raw_affiliation_string | Centro de Diagnóstico Biomédico, Hospital Clinic, Barcelona, Spain |
| authorships[21].institutions[0].id | https://openalex.org/I4210115097 |
| authorships[21].institutions[0].ror | https://ror.org/02a2kzf50 |
| authorships[21].institutions[0].type | healthcare |
| authorships[21].institutions[0].lineage | https://openalex.org/I4210115097 |
| authorships[21].institutions[0].country_code | ES |
| authorships[21].institutions[0].display_name | Hospital Clínic de Barcelona |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Aurea Mira |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Centro de Diagnóstico Biomédico, Hospital Clinic, Barcelona, Spain |
| authorships[22].author.id | https://openalex.org/A5071876778 |
| authorships[22].author.orcid | https://orcid.org/0000-0003-2888-6512 |
| authorships[22].author.display_name | Ana Vivancos |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I4387155398 |
| authorships[22].affiliations[0].raw_affiliation_string | Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain |
| authorships[22].institutions[0].id | https://openalex.org/I4387155398 |
| authorships[22].institutions[0].ror | https://ror.org/054xx3904 |
| authorships[22].institutions[0].type | healthcare |
| authorships[22].institutions[0].lineage | https://openalex.org/I4387153040, https://openalex.org/I4387155398 |
| authorships[22].institutions[0].country_code | |
| authorships[22].institutions[0].display_name | Vall d'Hebron Institute of Oncology |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Ana Vivancos |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain |
| authorships[23].author.id | https://openalex.org/A5080122151 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-8662-3641 |
| authorships[23].author.display_name | Patricia Villagrasa |
| authorships[23].countries | ES |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I4210144086 |
| authorships[23].affiliations[0].raw_affiliation_string | Reveal Genomics, Barcelona, Spain |
| authorships[23].institutions[0].id | https://openalex.org/I4210144086 |
| authorships[23].institutions[0].ror | https://ror.org/03n5zh241 |
| authorships[23].institutions[0].type | company |
| authorships[23].institutions[0].lineage | https://openalex.org/I4210144086 |
| authorships[23].institutions[0].country_code | ES |
| authorships[23].institutions[0].display_name | Oryzon Genomics (Spain) |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Patricia Villagrasa |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Reveal Genomics, Barcelona, Spain |
| authorships[24].author.id | https://openalex.org/A5054811851 |
| authorships[24].author.orcid | https://orcid.org/0000-0003-2080-6901 |
| authorships[24].author.display_name | Joel S. Parker |
| authorships[24].affiliations[0].raw_affiliation_string | Life Edit Therapeutics, North Carolina, USA |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Joel S. Parker |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | Life Edit Therapeutics, North Carolina, USA |
| authorships[25].author.id | https://openalex.org/A5034987953 |
| authorships[25].author.orcid | https://orcid.org/0000-0002-5210-5344 |
| authorships[25].author.display_name | Pierfranco Conté |
| authorships[25].countries | IT |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I4210109345, https://openalex.org/I4210153126 |
| authorships[25].affiliations[0].raw_affiliation_string | Medical Oncology 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy |
| authorships[25].affiliations[1].institution_ids | https://openalex.org/I138689650 |
| authorships[25].affiliations[1].raw_affiliation_string | Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy |
| authorships[25].institutions[0].id | https://openalex.org/I4210153126 |
| authorships[25].institutions[0].ror | https://ror.org/04tfzc498 |
| authorships[25].institutions[0].type | healthcare |
| authorships[25].institutions[0].lineage | https://openalex.org/I4210153126 |
| authorships[25].institutions[0].country_code | IT |
| authorships[25].institutions[0].display_name | Istituti di Ricovero e Cura a Carattere Scientifico |
| authorships[25].institutions[1].id | https://openalex.org/I4210109345 |
| authorships[25].institutions[1].ror | https://ror.org/01xcjmy57 |
| authorships[25].institutions[1].type | healthcare |
| authorships[25].institutions[1].lineage | https://openalex.org/I4210109345, https://openalex.org/I4210153126 |
| authorships[25].institutions[1].country_code | IT |
| authorships[25].institutions[1].display_name | Istituto Oncologico Veneto |
| authorships[25].institutions[2].id | https://openalex.org/I138689650 |
| authorships[25].institutions[2].ror | https://ror.org/00240q980 |
| authorships[25].institutions[2].type | education |
| authorships[25].institutions[2].lineage | https://openalex.org/I138689650 |
| authorships[25].institutions[2].country_code | IT |
| authorships[25].institutions[2].display_name | University of Padua |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Pierfranco Conte |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy, Medical Oncology 2, Istituto Oncologico Veneto, IRCCS, Padova, Italy |
| authorships[26].author.id | https://openalex.org/A5062498736 |
| authorships[26].author.orcid | https://orcid.org/0000-0001-9827-2247 |
| authorships[26].author.display_name | Charles M. Perou |
| authorships[26].countries | US |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I114027177, https://openalex.org/I4390039329 |
| authorships[26].affiliations[0].raw_affiliation_string | Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA |
| authorships[26].institutions[0].id | https://openalex.org/I4390039329 |
| authorships[26].institutions[0].ror | https://ror.org/043ehm030 |
| authorships[26].institutions[0].type | healthcare |
| authorships[26].institutions[0].lineage | https://openalex.org/I114027177, https://openalex.org/I4390039329 |
| authorships[26].institutions[0].country_code | |
| authorships[26].institutions[0].display_name | UNC Lineberger Comprehensive Cancer Center |
| authorships[26].institutions[1].id | https://openalex.org/I114027177 |
| authorships[26].institutions[1].ror | https://ror.org/0130frc33 |
| authorships[26].institutions[1].type | education |
| authorships[26].institutions[1].lineage | https://openalex.org/I114027177 |
| authorships[26].institutions[1].country_code | US |
| authorships[26].institutions[1].display_name | University of North Carolina at Chapel Hill |
| authorships[26].author_position | last |
| authorships[26].raw_author_name | Charles M. Perou |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://www.thelancet.com/article/S2352396421005958/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-07T23:20:04.922697 |
| primary_topic.id | https://openalex.org/T10755 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | HER2/EGFR in Cancer Research |
| related_works | https://openalex.org/W4385649027, https://openalex.org/W2365243064, https://openalex.org/W2970784617, https://openalex.org/W2126639667, https://openalex.org/W2386699790, https://openalex.org/W2217963778, https://openalex.org/W2503350049, https://openalex.org/W2329386257, https://openalex.org/W2129882004, https://openalex.org/W2410006919 |
| cited_by_count | 121 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 40 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 36 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 33 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 12 |
| locations_count | 6 |
| best_oa_location.id | doi:10.1016/j.ebiom.2021.103801 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2531685872 |
| best_oa_location.source.issn | 2352-3964 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2352-3964 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | EBioMedicine |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_lineage_names | Elsevier BV |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | http://www.thelancet.com/article/S2352396421005958/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | eBioMedicine |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.ebiom.2021.103801 |
| primary_location.id | doi:10.1016/j.ebiom.2021.103801 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2531685872 |
| primary_location.source.issn | 2352-3964 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2352-3964 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | EBioMedicine |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_lineage_names | Elsevier BV |
| primary_location.license | cc-by |
| primary_location.pdf_url | http://www.thelancet.com/article/S2352396421005958/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | eBioMedicine |
| primary_location.landing_page_url | https://doi.org/10.1016/j.ebiom.2021.103801 |
| publication_date | 2022-01-01 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W3188251561, https://openalex.org/W3192034436, https://openalex.org/W2461625475, https://openalex.org/W2908170962, https://openalex.org/W2889673459, https://openalex.org/W2948720210, https://openalex.org/W2806629158, https://openalex.org/W2948726637, https://openalex.org/W2624590002, https://openalex.org/W2768980003, https://openalex.org/W2902218997, https://openalex.org/W2006070721, https://openalex.org/W2910609377, https://openalex.org/W2947111998, https://openalex.org/W2144442992, https://openalex.org/W2998950563, https://openalex.org/W3094906946, https://openalex.org/W2468483329, https://openalex.org/W2591481727, https://openalex.org/W2096283457, https://openalex.org/W2005895632, https://openalex.org/W2149441684, https://openalex.org/W2792135005, https://openalex.org/W2162982444, https://openalex.org/W3093646952, https://openalex.org/W3208653333, https://openalex.org/W6795065385, https://openalex.org/W2120431466, https://openalex.org/W6677899853, https://openalex.org/W2806209829, https://openalex.org/W2517421365, https://openalex.org/W2928807055, https://openalex.org/W2942862617, https://openalex.org/W2524552969, https://openalex.org/W3042241047, https://openalex.org/W2475548831, https://openalex.org/W2171277704, https://openalex.org/W1969507803, https://openalex.org/W3188022781, https://openalex.org/W3031646075, https://openalex.org/W3119128530, https://openalex.org/W3018222852, https://openalex.org/W2175026167, https://openalex.org/W3159552494, https://openalex.org/W2121518671 |
| referenced_works_count | 45 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 99 |
| corresponding_author_ids | https://openalex.org/A5089513581 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 27 |
| corresponding_institution_ids | https://openalex.org/I4210114273, https://openalex.org/I4210115097, https://openalex.org/I4210133410, https://openalex.org/I4210160192, https://openalex.org/I71999127 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.5400000214576721 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.99268211 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |